Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome

[1] Ellies DL(1999)Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity J Bone Miner Res 21 1738-1749

[2] Viviano B(2004)Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST) J Biol Chem 279 13849-13858

[3] McCarthy J(2012)Sclerostin levels associated with inhibition of the Wnt/b-catenin signalling and reduced bone turnover in type 2 diabetes mellitus J Clin Endocrinol Metab 97 3744-3750

[4] Sevetson B(2015)1α,25-dihydroxy vitamin D stimulates human SOST gene expression and sclerostin secretion Mol Cell Endocrinol 413 157-167

[5] Taylor S(2005)SOST is a target gene for PTH in bone Bone 37 148-158

[6] Pan Y(2016)Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of sost/sclerostin J Bone Miner Res 31 1791-1802

[7] Gaudio A(2009)Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNF-alpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts J Bone Miner Res 24 1434-1449

[8] Privitera F(2011)Relation of age, gender, and bone mass to circulating sclerostin levels in women and men J Bone Miner Res 26 373-379

[9] Battaglia K(2009)Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signalling J Bone Miner Res 24 1651-1661

[10] Torrisi V(2017)Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes Proc Natl Acad Sci USA 114 E11238-E11247

[1] Ellies DL(1999)Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity J Bone Miner Res 21 1738-1749

[2] Viviano B(2004)Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST) J Biol Chem 279 13849-13858

[3] McCarthy J(2012)Sclerostin levels associated with inhibition of the Wnt/b-catenin signalling and reduced bone turnover in type 2 diabetes mellitus J Clin Endocrinol Metab 97 3744-3750

[4] Sevetson B(2015)1α,25-dihydroxy vitamin D stimulates human SOST gene expression and sclerostin secretion Mol Cell Endocrinol 413 157-167

[5] Taylor S(2005)SOST is a target gene for PTH in bone Bone 37 148-158

[6] Pan Y(2016)Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of sost/sclerostin J Bone Miner Res 31 1791-1802

[7] Gaudio A(2009)Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNF-alpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts J Bone Miner Res 24 1434-1449

[8] Privitera F(2011)Relation of age, gender, and bone mass to circulating sclerostin levels in women and men J Bone Miner Res 26 373-379

[9] Battaglia K(2009)Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signalling J Bone Miner Res 24 1651-1661

[10] Torrisi V(2017)Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes Proc Natl Acad Sci USA 114 E11238-E11247